Compare HRL & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRL | SNN |
|---|---|---|
| Founded | 1891 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Meat/Poultry/Fish | Industrial Specialties |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 14.0B |
| IPO Year | N/A | 1999 |
| Metric | HRL | SNN |
|---|---|---|
| Price | $24.48 | $33.44 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | $28.67 | ★ $32.83 |
| AVG Volume (30 Days) | ★ 5.3M | 467.0K |
| Earning Date | 12-04-2025 | 03-02-2026 |
| Dividend Yield | ★ 4.81% | 2.18% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | ★ 0.87 | 0.56 |
| Revenue | ★ $12,106,160,000.00 | $5,944,000,000.00 |
| Revenue This Year | $3.46 | $7.78 |
| Revenue Next Year | $2.75 | $5.13 |
| P/E Ratio | ★ $28.00 | $29.10 |
| Revenue Growth | 1.55 | ★ 5.35 |
| 52 Week Low | $21.03 | $23.69 |
| 52 Week High | $33.80 | $38.79 |
| Indicator | HRL | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 69.24 | 48.01 |
| Support Level | $22.85 | $32.68 |
| Resistance Level | $25.30 | $33.56 |
| Average True Range (ATR) | 0.48 | 0.41 |
| MACD | 0.25 | 0.14 |
| Stochastic Oscillator | 71.41 | 78.51 |
Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (62% of fiscal 2024 sales), US foodservice (32%), and international (6%). By product, 72% of fiscal 2024 sales were from perishable food and 28% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.